Home›Blog›Industry News

Is Compounded Semaglutide Legal? FDA Rules Explained (2026)

Compounding Finder Team·April 2, 2026·5 min read
Compounded semaglutide legality and FDA regulations

Is Compounded Semaglutide Still Legal?

Yes, but only under narrow clinical circumstances. The regulatory landscape changed significantly after the FDA resolved the semaglutide shortage in February 2025.

Back to: Compounded Semaglutide Overview

Timeline of Key Regulatory Changes

  • February 2025: The FDA formally declared the semaglutide shortage resolved, citing data from Novo Nordisk showing supply met demand.
  • April 2025: The enforcement discretion period ended for 503A compounding pharmacies preparing semaglutide.
  • 2026: Compounding pharmacies may still prepare semaglutide for patients with legitimate clinical needs.

What Changed After the Shortage Ended

During the shortage, compounding pharmacies had broader latitude to prepare semaglutide under Section 503A of the Federal Food, Drug, and Cosmetic Act. Now that the shortage is over, compounding is permitted only when there is a documented clinical need that cannot be met by the commercially available product.

Who Can Still Get Compounded Semaglutide?

A licensed prescriber must document one of these clinical justifications:

  • Allergy or sensitivity to inactive ingredients in branded Ozempic, Wegovy, or Rybelsus
  • Need for a non-standard dosage strength not commercially available
  • Requirement for an alternative dosage form (sublingual, troche, oral capsule)
  • Other documented medical necessity

Important: Cost or preference alone does not qualify a patient for compounded semaglutide.

503A vs. 503B Pharmacies

503A pharmacies compound medications based on individual patient-specific prescriptions. They are regulated primarily by state pharmacy boards.

503B outsourcing facilities can compound larger batches without patient-specific prescriptions and are registered with and inspected by the FDA.

Both types are legal pathways for compounded semaglutide, with different regulatory oversight.

CF
Compounding Finder Team
Helping patients find affordable compounded medications from licensed pharmacies across the US.
⚠️

We Do Not Currently Route Semaglutide Quote Requests

Semaglutide (Ozempic / Wegovy / Rybelsus) was removed from the FDA drug shortage list, so a compounding pharmacy can only prepare it when there is a specific, documented medical reason the brand will not work. If FDA guidance changes, we will revisit.

What actually works instead

The compliant path is the manufacturer's own pharmacy. Ask your prescriber to send the prescription there, or check your insurance coverage.

  • Wegovy through NovoCare Pharmacy

    Ask your prescriber to send your Wegovy prescription electronically to “NovoCare Pharmacy.” NovoCare Pharmacy handles payment and ships to your home directly.

    Get Wegovy at NovoCare Pharmacy →
  • Ozempic through NovoCare Pharmacy

    Ask your prescriber to send your Ozempic prescription electronically to “NovoCare Pharmacy.” NovoCare Pharmacy handles payment and ships to your home directly.

    Get Ozempic at NovoCare Pharmacy →
  • Compounded semaglutide and tirzepatide: what changed

    What the rules actually say, why pharmacies stopped, and the legitimate lower-cost paths that still exist.

    See your real options for semaglutide & tirzepatide →

Links to external price-comparison tools and retail pharmacies are provided for convenience. Compounding Finder is not affiliated with these services and does not receive information about your purchases. Always consult your prescriber before changing medications.

Published April 2, 2026